DHG Share Price Performance
₫102,800.00
-8200.00 (-7.39%)
Price ₫102,800.00
Share Price₫102,800.00
DHG Community Narratives
There are no narratives available yet.
Recent DHG News & Updates
No updates
DHG Pharmaceutical Joint Stock Company Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 6.42k
- Gross Margin
- 46.54%
- Net Profit Margin
- 17.13%
- Debt/Equity Ratio
- 24.5%
DHG Pharmaceutical Joint Stock Company Competitors
About DHG
- Founded
- 1974
- Employees
- 2794
- CEO
- WebsiteView website
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded in 1974 and is headquartered in Can Tho, Vietnam. DHG Pharmaceutical Joint Stock Company is a subsidiary of Taisho Pharmaceutical Co., Ltd.
Vietnamese Market Performance
- 7 Days: 4.3%
- 3 Months: 24.1%
- 1 Year: 28.7%
- Year to Date: 23.1%
The market is up 4.3% over the last week, with the Financials sector leading the way, up 5.7%. In the last year, the market has climbed 29%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading